Stock Events

Stock Events

Viridian Therapeutics (0K1R.LSE) Q3 2024 Earnings

8AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-1.35

-1.16

-0.98

-0.79

Details

Expected EPS

-0.870747

Actual EPS

-1.02

Surprise EPS

-0.15

Surprise Percent

+17.14%

Description

Viridian Therapeutics (0K1R.LSE) has reported earnings of -1.02 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.